Introduction
Currently in the UK over 10,000 major thoracic surgical procedures are performed each year. Chronic pain following thoracic surgery is common; the prevalence is often reported as )50% w1, 2x. This pain has a significant impact on patients' lives; )40% report that pain is their worst problem and that it limits their daily activities w1x.
The cause of chronic pain following thoracic surgery is not fully understood, however, intercostal nerve damage and subsequent dysfunction has long been implicated in the development of chronic pain symptoms. Animal models of thoracotomy pain have demonstrated neuropathic symptoms (such as allodynia, following rib retraction) and patients with objective signs of nerve damage (such as loss of superficial abdominal reflexes) following surgery experience more severe acute and chronic pain w3-5x. Maguire et al. investigated intercostal nerve damage at the time of operation and demonstrated two patterns of nerve injury, suggesting this reflected damage from pressure related to rib retraction and damage caused by traction on the nerve w6x.
Neuropathic pain mechanisms are, therefore, likely to contribute towards the postoperative pain experience, however, few studies have investigated the epidemiology of neuropathic pain following thoracic surgery. In a retrospective postal survey of 600 thoracic surgery patients Maguire et al. concluded that chronic neuropathic pain (CNP) symptoms were common and associated with pain that is more severe, less likely to improve with time, has a greater impact on patients' lives, involves more analgesia use, limits daily activities and is their worst medical problem w1x. More recently Steegers et al. used a validated questionnaire to determine the incidence of CNP following thoracic surgery, concluding that of those with chronic pain, 53% had neuropathic pain w7x. However, these studies were retrospective postal surveys, conducted at widely varying time points from the original surgery, with no information on the existence of neuropathic pain before the operation. It is clear that CNP does occur following thoracic surgery, however, the proportion of patients experiencing acute neuropathic pain (ANP) in the thoracic surgery population is not known. Although pain intensity in the immediate postoperative period is known to be related to the development of chronic pain after thoracic surgery, it is not known if pain character predicts development of CNP in this surgical population w8x. We aimed to determine the incidence of ANP and CNP following thoracic surgery and hypothesized that the occurrence of ANP characteristics following thoracic surgery would be associated with significantly higher odds of developing CNP characteristics at three months follow-up.
Methods
The study was designed as a prospective, observational cohort study. After Ethics Committee approval, adult patients admitted to St James's University Hospital (Leeds, UK) for video assisted thoracic surgery (VATS) or posterolateral thoracotomy were recruited. Patients were excluded if they had previously undergone VATS or thoracotomy, had previously diagnosed neuropathic pain or were pregnant. We wanted to assess the proportion of patients who experienced ANP characteristics following thoracic surgery and the subsequent incidence of CNP characteristics three months later. To do this we used validated neuropathic pain screening tools: Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and the related self-complete version (S-LANSS) w9, 10x. These tools are designed to identify patients with pain of predominantly neuropathic origin and positive scores are indicative of neuropathic pain but are not diagnostic. We used screening tools rather than clinician assessment alone, to ensure consistency and reduce missing data between assessments in the acute and follow-up periods.
Following informed consent, a medical researcher performed a baseline preoperative LANSS score on the day before scheduled surgery (performing the examination items at the expected site of surgery). Patients who had positive LANSS scores at this stage were withdrawn from the study. Patient demographics and the operation performed were recorded. During the postoperative period the medical researcher repeated the LANSS score whilst the patient was in hospital. This examination was conducted at least 24 h after regional or local anaesthetic infusion or injection had ceased. Three months following their operation, patients were sent an S-LANSS questionnaire by post. This self-report version of the LANSS score included a numerical rating scale (anchored 0: no pain and 10: severe pain) recording pain intensity. Those failing to return the postal questionnaire were telephoned after a further two weeks and where possible the S-LANSS was completed by telephone interview.
Pain in patients with a LANSS or S-LANSS score G12 was considered to be neuropathic.
Patients undergoing thoracotomy were positioned on the appropriate lateral side, and a standard posterolateral thoracotomy was performed with division of the latissimus dorsi muscle and sparing of serratus anterior muscle. Division of rib was not performed and the ribs were spread using a Holme-Sellars self-retaining retractor. Patients undergoing VATS procedures had between one and three ports depending on the procedure performed. If more than one port was used, where possible these were placed in the same intercostal space.
A paravertebral catheter was placed under direct vision at the end of the surgical procedure in a number of patients, as outlined in the results.
Relative risks were used to express and quantify any association between ANP and CNP, with Fisher's exact test being used to calculate the significance of any such associations in this, and in other, 2=2 contingency tables. Any possible relationships between CNP and other factors (such as the preoperative LANSS score) were investigated using stepwise logistic regression analysis with the statistical package STATA. Relative risks and their associated confidence intervals (CIs) were calculated as described by Altman w11x.
Results
One hundred and fifteen patients were recruited to the study between October 2007 and September 2008. Fifteen patients were withdrawn from the study: one patient was excluded because of neuropathic pain identified preoperatively, one patient died in the postoperative period and one patient withdrew consent. Twelve patients were recruited but had their operation cancelled, postponed or did not proceed to VATS or thoracotomy. Of the remaining 100 patients the mean age was 62 years (range, 17-88), 64% were male and 65% had a malignant diagnosis. Details of patients receiving different surgical and analgesic techniques are shown in Tables 1 and 2 . Patients receiving paravertebral analgesia had a surgically placed catheter and continuous infusion of plain bupivicaine during the postoperative period.
None of the 100 patients had preoperative neuropathic pain (LANSS G12). The postoperative LANSS score was performed an average of three days following surgery in each of the three surgical procedure groups (VATS, thoracotomy and both VATS and thoracotomy). Eight (8%) patients developed ANP in the early postoperative period (LANSS score G12). Eighty-seven of these 100 patients subsequently completed postal or telephone S-LANSS questionnaires an average (mean) of 110 days following their operation (range, 86-213 days). Of these 87 patients, 19 (22%) had CNP (S-LANSS G12). Eighty-five of the 100 patients completed the numerical rating scores (NRS) pain intensity scale at follow-up. Of these, 53 (62%) had chronic pain, and of those patients with chronic pain 18 (21%) had a pain score of between 5 and 10 on the NRS scale.
Patients with ANP were more likely to have CNP at three months than those without ANP w5y8 (62.5%) vs. 14y79 (18%), relative risk 3.5 (95% CI 1.7-7.2)x. Looking at the individual items of the postoperative LANSS scores, item one (Does your pain feel like strange, unpleasant sensations in your skin? Words like prickling, tingling, pins and needles might describe these sensations) was more predictive of three months CNP, with a relative risk of 4.5 (95% CI 2.3-8.7), with 7y10 (70%) of patients who answered 'yes' to this question developing CNP, compared with 12y77 (16%) of those who answered 'no'. In a multivariate logistic regression the other six components of the postoperative LANSS score did not add to the predictive capacity of question one. Their (univariate) logistic model correlations are given in Table 3 , with numbers and proportions answering 'yes' to each of the individual questions postoperatively and at three months.
Patients with CNP had significantly higher average LANSS scores during the postoperative period (medians7) than those who did not develop chronic pain (medians3, Ps0.007 Mann-Whitney U-test). There was no correlation between CNP and gender, type of operation or whether the underlying disease diagnosis was malignant or benign. Older patients were more likely to have CNP (Ps0.04); although this was not significant once the postoperative LANSS score was included in a multivariate predictive model. Univariate and multivariate logistic regression analysis demonstrated no single analgesic technique was associated with the subsequent development of CNP.
There was a correlation between the total postoperative LANSS score and the later three months S-LANSS total; r-value of 0.33 (P-0.001). Patients with CNP (S-LANSS G12) had significantly higher NRS (medians5) than those with nociceptive pain (medians2, Ps0.002 Mann-Whitney U-test) at three months follow-up. There was no significant correlation between the postoperative LANSS score and the three-month NRS pain intensity score (medians1 for nociceptive pain; median 3.5 for neuropathic pain, Ps0.09).
Discussion
We found that 8% of patients undergoing major thoracic surgery developed ANP characteristics in the immediate postoperative period and that 22% of patients have CNP characteristics three months after their operation. Furthermore, our study demonstrates that the presence of acute pain of predominantly neuropathic origin is significantly associated with development of CNP characteristics three months later.
Maguire et al. demonstrated CNP symptoms in 35-85% of patients with pain in a postal questionnaire survey of post-thoracic surgery patients, although they did not use a validated neuropathic pain tool w1x. More recently, researchers demonstrated 23% of patients had CNP in a result very similar to our own, using a different validated scale w7x. The prevalence of ANP symptoms in this population has not been previously described. Hayes et al. estimated the incidence of ANP as 1-3% of all surgical patients, although this study only included one case following thoracotomy and patients were not screened for pre-existing neuropathic pain w12x. Our results show a small but significant proportion of thoracic surgery patients have ANP characteristics and importantly that this predicts the development of CNP. However, three patients with acute neuropathic characteristics did not develop CNP, suggesting that the natural history of acute neuropathic symptoms and signs may be that over a third of cases spontaneously resolve in the first three months.
The majority of patients who developed CNP (74%) did not have neuropathic pain characteristics in the immediate postoperative period, although they had significantly higher average LANSS scores compared to patients who did not develop CNP. It is not clear whether this reflects a different pathophysiological process, or if it reflects a reduction in the sensitivity of the LANSS score when used in the early postoperative period. Although the LANSS score has been validated in a mixed population of patients with neuropathic pain, it has not been specifically designed for use in the early postoperative period w9x. However, despite this it has been used successfully in other acute pain contexts and it remains an easy to use bedside tool for identifying neuropathic pain w13x. More work is needed to develop a validated tool to aid diagnosis of neuropathic pain in the immediate postoperative period.
Identification of ANP offers opportunities to test interventions to reduce the development of CNP and we believe that further research is needed in this area. However, it is important to note that the majority of patients with CNP do not have sufficient symptoms and signs of neuropathic pain in the immediate postoperative period for a diagnosis of ANP, although they do have significantly higher average postoperative LANSS scores. Few studies have looked at the impact of peri-operative antineuropathic medication to reduce chronic post-surgical pain, and the results are inconclusive w14, 15x.
In summary, ANP following major thoracic surgery predicts the development of CNP and therefore, offers the opportunity to screen and to intervene to reduce the development of CNP. However, screening for chronic pain at surgical follow-up remains important.
